STOCK TITAN

Insmed (NASDAQ: INSM) director reports bona fide 100-share stock gift

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

INSMED Inc director Melvin Sharoky, MD reported a bona fide gift of common stock. On March 3, 2026, an entity associated with him transferred 100 shares of common stock as a gift transfer at a reported price of $0.0000 per share, reducing his directly held shares to 242,776.

He also reported several indirect holdings: 6,847 shares held by his spouse, 5,000 shares held by Padonia, LLC, where he is the managing member, and custodial UTMA/FL accounts holding 819, 5,423, 5,007, and 3,724 shares for named family beneficiaries.

Positive

  • None.

Negative

  • None.
Insider SHAROKY MELVIN MD
Role Director
Type Security Shares Price Value
Gift Common Stock 100 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 242,776 shares (Direct); Common Stock — 6,847 shares (Indirect, By spouse)
Footnotes (1)
  1. The Reporting Person is the managing member of Padonia, LLC. The Reporting Person is the custodian of Melvin Sharoky C/F Adler J. Wink UTMA/FL. The Reporting Person is the custodian of Melvin Sharoky C/F Nolan M. Wink UTMA/FL. The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL. The Reporting Person is the custodian of Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SHAROKY MELVIN MD

(Last) (First) (Middle)
700 US HIGHWAY 202/206

(Street)
BRIDGEWATER NJ 08807

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INSMED Inc [ INSM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/03/2026 G 100 D $0 242,776 D
Common Stock 6,847 I By spouse
Common Stock 5,000 I By Padonia, LLC(1)
Common Stock 819 I By Melvin Sharoky C/F Adler J. Wink UTMA/FL(2)
Common Stock 5,423 I By Melvin Sharoky C/F Nolan M. Wink UTMA/FL(3)
Common Stock 5,007 I By Melvin Sharoky C/F Sophie C. Wink UTMA/FL(4)
Common Stock 3,724 I By Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The Reporting Person is the managing member of Padonia, LLC.
2. The Reporting Person is the custodian of Melvin Sharoky C/F Adler J. Wink UTMA/FL.
3. The Reporting Person is the custodian of Melvin Sharoky C/F Nolan M. Wink UTMA/FL.
4. The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.
5. The Reporting Person is the custodian of Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL.
Remarks:
/s/ Melvin Sharoky, M.D, by Michael A. Smith as Attorney-in-fact 03/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did INSM director Melvin Sharoky report?

INSM director Melvin Sharoky, MD reported a bona fide gift of common stock. On March 3, 2026, an associated account transferred 100 shares of Insmed common stock as a gift at a reported price of $0.0000 per share, reducing his directly held balance.

How many INSMED Inc shares does Melvin Sharoky hold directly after the gift?

After the reported gift, Melvin Sharoky directly holds 242,776 Insmed common shares. This figure reflects his direct ownership position following the transfer of 100 shares classified as a bona fide gift on March 3, 2026, according to the Form 4 disclosure.

What is Padonia, LLC’s role in Melvin Sharoky’s INSM holdings?

Padonia, LLC holds 5,000 Insmed common shares as an indirect ownership position for Melvin Sharoky. The filing states he is the managing member of Padonia, LLC, linking his beneficial interest to those shares while distinguishing them from his directly owned 242,776-share position.

Which UTMA/FL custodial accounts did Melvin Sharoky report for INSM shares?

Custodial UTMA/FL accounts show Insmed shares held for Adler J. Wink, Nolan M. Wink, Sophie C. Wink, and Tulia L. Sharoky. Reported balances are 819, 5,423, 5,007, and 3,724 shares respectively, with Sharoky disclosed as custodian for each account under Florida UTMA rules.

Was the reported INSM stock transfer a sale or a gift?

The reported Insmed stock transfer was a gift, not a sale. The Form 4 lists transaction code G, described as a “bona fide gift,” for 100 common shares at a stated price of $0.0000 per share, indicating a non-sale, no‑consideration disposition.